UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A study about return policies in the presence of consumer social learning

Production and operations management, 2022-06, Vol.31 (6), p.2571-2587

2022

Volltextzugriff (PDF)

RBD conjugate vaccine with a built-in TLR1/2 agonist is highly immunogenic against SARS-CoV-2 and variants of concern

Chemical communications (Cambridge, England), 2022-02, Vol.58 (13), p.212-2123

2022

Volltextzugriff (PDF)

A protein vaccine with Alum/c-GAMP/poly(I:C) rapidly boosts robust immunity against SARS-CoV-2 and variants of concern

Chemical communications (Cambridge, England), 2022-03, Vol.58 (24), p.3925-3928

2022

Volltextzugriff (PDF)

Alum Adjuvant and Built-in TLR7 Agonist Synergistically Enhance Anti-MUC1 Immune Responses for Cancer Vaccine

Frontiers in immunology, 2022-03, Vol.13, p.857779-857779

2022

Volltextzugriff (PDF)

Liposomal Antitumor Vaccines Targeting Mucin 1 Elicit a Lipid‐Dependent Immunodominant Response

Chemistry, an Asian journal, 2019-06, Vol.14 (12), p.2116-2121

2019

Volltextzugriff (PDF)

Lack of gene flow between Phytophthora infestans populations of two neighboring countries with the largest potato production

Evolutionary applications, 2020-02, Vol.13 (2), p.318-329

2020

Volltextzugriff (PDF)

Poly(I:C)/c-GAMP/Alum ternary adjuvant system synergistically enhances the immunogenicity of glycopeptide antigen

Journal of carbohydrate chemistry, 2023-11, Vol.42 (7-9), p.252-267

2023

Volltextzugriff (PDF)

MUC1 Specific Immune Responses Enhanced by Coadministration of Liposomal DDA/MPLA and Lipoglycopeptide

Frontiers in chemistry, 2022-02, Vol.10, p.814880-814880

2022

Volltextzugriff (PDF)

Multifunctional Protein Conjugates with Built-in Adjuvant (Adjuvant-Protein-Antigen) as Cancer Vaccines Boost Potent Immune Responses

iScience, 2020-03, Vol.23 (3), p.100935-100935, Article 100935

2020

Volltextzugriff (PDF)

MPLA-Adjuvanted Liposomes Encapsulating S‑Trimer or RBD or S1, but Not S‑ECD, Elicit Robust Neutralization Against SARS-CoV‑2 and Variants of Concern

Journal of medicinal chemistry, 2022-02, Vol.65 (4), p.3563-3574

2022

Volltextzugriff (PDF)

Novel sialoglycan linkage for constructing adjuvant-protein conjugate as potent vaccine for COVID-19

Journal of controlled release, 2023-03, Vol.355, p.238-247

2023

Volltextzugriff (PDF)

Multifunctional Lipidated Protein Carrier with a Built-In Adjuvant as a Universal Vaccine Platform Potently Elevates Immunogenicity of Weak Antigens

Journal of medicinal chemistry, 2024-04, Vol.67 (8), p.6822-6838

2024

Volltextzugriff (PDF)

Self-Adjuvanting Lipoprotein Conjugate αGalCer-RBD Induces Potent Immunity against SARS-CoV‑2 and its Variants of Concern

Journal of medicinal chemistry, 2022-02, Vol.65 (3), p.2558-2570

2022

Volltextzugriff (PDF)

pH-Sensitive and Biodegradable Mn3(PO4)2·3H2O Nanoparticles as an Adjuvant of Protein-Based Bivalent COVID-19 Vaccine to Induce Potent and Broad-Spectrum Immunity

ACS applied materials & interfaces, 2023-02, Vol.15 (7), p.8914-8926

2023

Volltextzugriff (PDF)

Self-Adjuvanting Protein Vaccine Conjugated with a Novel Synthetic TLR4 Agonist on Virus-Like Liposome Induces Potent Immunity against SARS-CoV‑2

Journal of medicinal chemistry, 2023-01, Vol.66 (2), p.1467-1483

2023

Volltextzugriff (PDF)

Adjuvant-Free COVID-19 Vaccine with Glycoprotein Antigen Oxidized by Periodate Rapidly Elicits Potent Immune Responses

ACS chemical biology, 2023-04, Vol.18 (4), p.915-923

2023

Volltextzugriff (PDF)

Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV‑2 and Variants of Concern

ACS infectious diseases, 2022-07, Vol.8 (7), p.1367-1375

2022

Volltextzugriff (PDF)

Epidemiological Survey of Hemoglobinopathies Based on Next-Generation Sequencing Platform in Hunan Province, China

Biomedical and environmental sciences, 2023-02, Vol.36 (2), p.127-134

2023

Volltextzugriff (PDF)

Performance analysis of non-invasive prenatal testing for trisomy 13, 18, and 21: A large-scale retrospective study (2018–2021)

Heliyon, 2024-07, Vol.10 (13), p.e33437, Article e33437

2024

Volltextzugriff (PDF)

Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion

Cell research, 2013-04, Vol.23 (4), p.508-523

2013

Volltextzugriff (PDF)

Reaction Mechanism Spectroscopy Studies of Protein and Orange II

Chemical engineering transactions, 2015-12, Vol.46

2015

Volltextzugriff (PDF)

Effect of high-intensity vibration parameter on droplet transport characteristics in gas channel of proton exchange membrane fuel cell

International communications in heat and mass transfer, 2024-09, Vol.157, p.107785, Article 107785

2024

Volltextzugriff (PDF)

Rationally Designed Highly Potent NKT Cell Agonists with Different Cytokine Selectivity through Hydrogen-Bond Interaction

Journal of medicinal chemistry, 2024-08, Vol.67 (15), p.12819-12834

2024

Volltextzugriff (PDF)

The genetics and clinical outcomes in 151 cases of fetal growth restriction: A Chinese single-center study

European journal of obstetrics & gynecology and reproductive biology, 2024-07, Vol.298, p.128-134

2024

Volltextzugriff (PDF)

Conjugation of TLR7 and TLR7/8 agonists onto weak protein antigen via versatile oxime ligation for enhanced vaccine efficacy

International journal of biological macromolecules, 2024-10, Vol.278 (Pt 1), p.134620, Article 134620

2024

Volltextzugriff (PDF)

1 – 25 von 367

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(291)
Mit Volltextzugriff
(321)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(254)
Life Sciences & Biomedicine
(153)
Humans
(69)
Technology
(63)
Physical Sciences
(56)
Engineering
(37)
Animals
(34)
Chemistry
(34)
Female
(31)
Mice
(31)
Male
(30)
Materials Science
(29)
Pharmacology & Pharmacy
(26)
Cell Biology
(23)
Science & Technology - Other Topics
(21)
Biochemistry & Molecular Biology
(20)
Chemistry, Medicinal
(19)
Environmental Sciences
(18)
Materials Science, Multidisciplinary
(18)
Middle Aged
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

A study about return policies in the presence of consumer social learning

RBD conjugate vaccine with a built-in TLR1/2 agonist is highly immunogenic against SARS-CoV-2 and variants of concern

A protein vaccine with Alum/c-GAMP/poly(I:C) rapidly boosts robust immunity against SARS-CoV-2 and variants of concern

Alum Adjuvant and Built-in TLR7 Agonist Synergistically Enhance Anti-MUC1 Immune Responses for Cancer Vaccine

Liposomal Antitumor Vaccines Targeting Mucin 1 Elicit a Lipid‐Dependent Immunodominant Response

Lack of gene flow between Phytophthora infestans populations of two neighboring countries with the largest potato production

Poly(I:C)/c-GAMP/Alum ternary adjuvant system synergistically enhances the immunogenicity of glycopeptide antigen

MUC1 Specific Immune Responses Enhanced by Coadministration of Liposomal DDA/MPLA and Lipoglycopeptide

Multifunctional Protein Conjugates with Built-in Adjuvant (Adjuvant-Protein-Antigen) as Cancer Vaccines Boost Potent Immune Responses

MPLA-Adjuvanted Liposomes Encapsulating S‑Trimer or RBD or S1, but Not S‑ECD, Elicit Robust Neutralization Against SARS-CoV‑2 and Variants of Concern

Novel sialoglycan linkage for constructing adjuvant-protein conjugate as potent vaccine for COVID-19

Multifunctional Lipidated Protein Carrier with a Built-In Adjuvant as a Universal Vaccine Platform Potently Elevates Immunogenicity of Weak Antigens

Self-Adjuvanting Lipoprotein Conjugate αGalCer-RBD Induces Potent Immunity against SARS-CoV‑2 and its Variants of Concern

pH-Sensitive and Biodegradable Mn3(PO4)2·3H2O Nanoparticles as an Adjuvant of Protein-Based Bivalent COVID-19 Vaccine to Induce Potent and Broad-Spectrum Immunity

Self-Adjuvanting Protein Vaccine Conjugated with a Novel Synthetic TLR4 Agonist on Virus-Like Liposome Induces Potent Immunity against SARS-CoV‑2

Adjuvant-Free COVID-19 Vaccine with Glycoprotein Antigen Oxidized by Periodate Rapidly Elicits Potent Immune Responses

Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV‑2 and Variants of Concern

Epidemiological Survey of Hemoglobinopathies Based on Next-Generation Sequencing Platform in Hunan Province, China

Performance analysis of non-invasive prenatal testing for trisomy 13, 18, and 21: A large-scale retrospective study (2018–2021)

Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion

Reaction Mechanism Spectroscopy Studies of Protein and Orange II

Effect of high-intensity vibration parameter on droplet transport characteristics in gas channel of proton exchange membrane fuel cell

Rationally Designed Highly Potent NKT Cell Agonists with Different Cytokine Selectivity through Hydrogen-Bond Interaction

The genetics and clinical outcomes in 151 cases of fetal growth restriction: A Chinese single-center study

Conjugation of TLR7 and TLR7/8 agonists onto weak protein antigen via versatile oxime ligation for enhanced vaccine efficacy

Suchergebnisse filtern